Selected research
Industry Research
Protein G Sepharose Industry Research Report 2026
Market perspective
The global Protein G Sepharose market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Protein G Sepharose is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Protein G Sepharose is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Protein G Sepharose is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Protein G Sepharose include Merck, Thermo Fisher Scientific, Abcam, Calibre Scientific, Chondrex, SERVA Electrophoresis, Neo Biotech, Rockland and M&S TechnoSystems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Protein G Sepharose market in terms of revenue (US$ million) and, where applicable, sales volume (k L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Protein G Sepharose Market by Company
Merck
Thermo Fisher Scientific
Abcam
Calibre Scientific
Chondrex
SERVA Electrophoresis
Neo Biotech
Rockland
M&S TechnoSystems
MedChemExpress
Yeasen
TargetMol
bersee
Heyuan Liji
Fujian Herui biotechnology
Protein G Sepharose Segment by Type
Covalent Coupling Type
Non-covalent Adsorption Type
Protein G Sepharose Segment by Application
Antibody Purification
Biopharmaceutical and Vaccine Research and Development
Diagnostic Reagent Development
Proteomics Research
Others
Protein G Sepharose Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Protein G Sepharose market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Protein G Sepharose and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Protein G Sepharose.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Protein G Sepharose manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Protein G Sepharose by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Protein G Sepharose in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Covalent Coupling Type
- Non-covalent Adsorption Type
Applications
- Antibody Purification
- Biopharmaceutical and Vaccine Research and Development
- Diagnostic Reagent Development
- Proteomics Research
- Others
Companies covered
- Merck
- Thermo Fisher Scientific
- Abcam
- Calibre Scientific
- Chondrex
- SERVA Electrophoresis
- Neo Biotech
- Rockland
- M&S TechnoSystems
- MedChemExpress
- Yeasen
- TargetMol
- bersee
- Heyuan Liji
- Fujian Herui biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Protein G Sepharose Market Size (2021-2032)
- 2.2.2 Global Protein G Sepharose Sales (2021-2032)
- 2.2.3 Global Protein G Sepharose Market Average Price (2021-2032)
- 2.3 Protein G Sepharose by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Covalent Coupling Type
- 2.3.3 Non-covalent Adsorption Type
- 2.4 Protein G Sepharose by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Antibody Purification
- 2.4.3 Biopharmaceutical and Vaccine Research and Development
- 2.4.4 Diagnostic Reagent Development
- 2.4.5 Proteomics Research
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Protein G Sepharose Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Protein G Sepharose Sales (k L) of Manufacturers (2021-2026)
- 3.3 Global Protein G Sepharose Revenue of Manufacturers (2021-2026)
- 3.4 Global Protein G Sepharose Average Price by Manufacturers (2021-2026)
- 3.5 Global Protein G Sepharose Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Protein G Sepharose, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Protein G Sepharose, Product Type & Application
- 3.8 Global Manufacturers of Protein G Sepharose, Established Date
- 3.9 Global Protein G Sepharose Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Protein G Sepharose Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Thermo Fisher Scientific
- 4.2.1 Thermo Fisher Scientific Company Information
- 4.2.2 Thermo Fisher Scientific Business Overview
- 4.2.3 Thermo Fisher Scientific Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific Protein G Sepharose Product Portfolio
- 4.2.5 Thermo Fisher Scientific Recent Developments
- 4.3 Abcam
- 4.3.1 Abcam Company Information
- 4.3.2 Abcam Business Overview
- 4.3.3 Abcam Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abcam Protein G Sepharose Product Portfolio
- 4.3.5 Abcam Recent Developments
- 4.4 Calibre Scientific
- 4.4.1 Calibre Scientific Company Information
- 4.4.2 Calibre Scientific Business Overview
- 4.4.3 Calibre Scientific Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Calibre Scientific Protein G Sepharose Product Portfolio
- 4.4.5 Calibre Scientific Recent Developments
- 4.5 Chondrex
- 4.5.1 Chondrex Company Information
- 4.5.2 Chondrex Business Overview
- 4.5.3 Chondrex Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Chondrex Protein G Sepharose Product Portfolio
- 4.5.5 Chondrex Recent Developments
- 4.6 SERVA Electrophoresis
- 4.6.1 SERVA Electrophoresis Company Information
- 4.6.2 SERVA Electrophoresis Business Overview
- 4.6.3 SERVA Electrophoresis Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SERVA Electrophoresis Protein G Sepharose Product Portfolio
- 4.6.5 SERVA Electrophoresis Recent Developments
- 4.7 Neo Biotech
- 4.7.1 Neo Biotech Company Information
- 4.7.2 Neo Biotech Business Overview
- 4.7.3 Neo Biotech Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Neo Biotech Protein G Sepharose Product Portfolio
- 4.7.5 Neo Biotech Recent Developments
- 4.8 Rockland
- 4.8.1 Rockland Company Information
- 4.8.2 Rockland Business Overview
- 4.8.3 Rockland Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Rockland Protein G Sepharose Product Portfolio
- 4.8.5 Rockland Recent Developments
- 4.9 M&S TechnoSystems
- 4.9.1 M&S TechnoSystems Company Information
- 4.9.2 M&S TechnoSystems Business Overview
- 4.9.3 M&S TechnoSystems Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 M&S TechnoSystems Protein G Sepharose Product Portfolio
- 4.9.5 M&S TechnoSystems Recent Developments
- 4.10 MedChemExpress
- 4.10.1 MedChemExpress Company Information
- 4.10.2 MedChemExpress Business Overview
- 4.10.3 MedChemExpress Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 MedChemExpress Protein G Sepharose Product Portfolio
- 4.10.5 MedChemExpress Recent Developments
- 4.11 Yeasen
- 4.11.1 Yeasen Company Information
- 4.11.2 Yeasen Business Overview
- 4.11.3 Yeasen Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Yeasen Protein G Sepharose Product Portfolio
- 4.11.5 Yeasen Recent Developments
- 4.12 TargetMol
- 4.12.1 TargetMol Company Information
- 4.12.2 TargetMol Business Overview
- 4.12.3 TargetMol Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 TargetMol Protein G Sepharose Product Portfolio
- 4.12.5 TargetMol Recent Developments
- 4.13 bersee
- 4.13.1 bersee Company Information
- 4.13.2 bersee Business Overview
- 4.13.3 bersee Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 bersee Protein G Sepharose Product Portfolio
- 4.13.5 bersee Recent Developments
- 4.14 Heyuan Liji
- 4.14.1 Heyuan Liji Company Information
- 4.14.2 Heyuan Liji Business Overview
- 4.14.3 Heyuan Liji Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Heyuan Liji Protein G Sepharose Product Portfolio
- 4.14.5 Heyuan Liji Recent Developments
- 4.15 Fujian Herui biotechnology
- 4.15.1 Fujian Herui biotechnology Company Information
- 4.15.2 Fujian Herui biotechnology Business Overview
- 4.15.3 Fujian Herui biotechnology Protein G Sepharose Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Fujian Herui biotechnology Protein G Sepharose Product Portfolio
- 4.15.5 Fujian Herui biotechnology Recent Developments
5 Global Protein G Sepharose Market Scenario by Region
- 5.1 Global Protein G Sepharose Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Protein G Sepharose Sales by Region: 2021-2032
- 5.2.1 Global Protein G Sepharose Sales by Region: 2021-2026
- 5.2.2 Global Protein G Sepharose Sales by Region: 2027-2032
- 5.3 Global Protein G Sepharose Revenue by Region: 2021-2032
- 5.3.1 Global Protein G Sepharose Revenue by Region: 2021-2026
- 5.3.2 Global Protein G Sepharose Revenue by Region: 2027-2032
- 5.4 North America Protein G Sepharose Market Facts & Figures by Country
- 5.4.1 North America Protein G Sepharose Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Protein G Sepharose Sales by Country (2021-2032)
- 5.4.3 North America Protein G Sepharose Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Protein G Sepharose Market Facts & Figures by Country
- 5.5.1 Europe Protein G Sepharose Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Protein G Sepharose Sales by Country (2021-2032)
- 5.5.3 Europe Protein G Sepharose Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Protein G Sepharose Market Facts & Figures by Country
- 5.6.1 Asia Pacific Protein G Sepharose Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Protein G Sepharose Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Protein G Sepharose Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Protein G Sepharose Market Facts & Figures by Country
- 5.7.1 South America Protein G Sepharose Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Protein G Sepharose Sales by Country (2021-2032)
- 5.7.3 South America Protein G Sepharose Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Protein G Sepharose Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Protein G Sepharose Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Protein G Sepharose Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Protein G Sepharose Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Protein G Sepharose Sales by Type (2021-2032)
- 6.1.1 Global Protein G Sepharose Sales by Type (2021-2032) & (k L)
- 6.1.2 Global Protein G Sepharose Sales Market Share by Type (2021-2032)
- 6.2 Global Protein G Sepharose Revenue by Type (2021-2032)
- 6.2.1 Global Protein G Sepharose Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Protein G Sepharose Revenue Market Share by Type (2021-2032)
- 6.3 Global Protein G Sepharose Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Protein G Sepharose Sales by Application (2021-2032)
- 7.1.1 Global Protein G Sepharose Sales by Application (2021-2032) & (k L)
- 7.1.2 Global Protein G Sepharose Sales Market Share by Application (2021-2032)
- 7.2 Global Protein G Sepharose Revenue by Application (2021-2032)
- 7.2.1 Global Protein G Sepharose Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Protein G Sepharose Revenue Market Share by Application (2021-2032)
- 7.3 Global Protein G Sepharose Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Protein G Sepharose Value Chain Analysis
- 8.1.1 Protein G Sepharose Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Protein G Sepharose Production Mode & Process
- 8.2 Protein G Sepharose Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Protein G Sepharose Distributors
- 8.2.3 Protein G Sepharose Customers
9 Global Protein G Sepharose Analyzing Market Dynamics
- 9.1 Protein G Sepharose Industry Trends
- 9.2 Protein G Sepharose Industry Drivers
- 9.3 Protein G Sepharose Industry Opportunities and Challenges
- 9.4 Protein G Sepharose Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst